Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARMA Fact Sheet   (BAFNPH)


Potential 1000% Gains: 3 Stocks at The Heart of The Big India Revival


Here is the latest financial fact sheet of BAFNA PHARMA. For more details, see the BAFNA PHARMA quarterly results and BAFNA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

BAFNA PHARMA Price History

Price Rs 100.0
Mkt Cap Rs m 2,366
Vol '000 0.0
P/E X 53.4
P/CF X 22.2
EPS (TTM) Rs 1.9
1 Day % -1.4
No. of shares m 23.66
1 Week % -2.8
1 Month % -13.0
1 Year % -23.1
52 week H/L Rs 190.7/97.4
As on Oct 3, 2022 12:50:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAFNA PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
BAFNA PHARMA EQUITY SHARE DATA
High Rs323011196191 
Low Rs20959115 
Sales per share (Unadj.) Rs19.918.4179.230.136.0 
Earnings per share (Unadj.) Rs-7.1-8.2-7.92.52.2 
Diluted earnings per shareRs-7.1-8.2-0.82.52.2 
Cash flow per share (Unadj.) Rs-5.5-6.75.84.44.5 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs16.08.1-17.924.026.6 
Adj. book value per shareRs16.08.1-1.824.026.6 
Shares outstanding (eoy) m23.6623.662.3723.6623.66 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.31.103.44.2 
Avg P/E ratio x-3.7-2.4-1.041.770.2 
P/CF ratio (eoy) x-4.8-2.91.323.634.0 
Price / Book Value ratio x1.62.4-0.44.35.8 
Dividend payout %00000 
Avg Mkt Cap Rs m620462182,4283,616 
No. of employees `000NANANANANA 
Total wages/salary Rs m7590103120145 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BAFNA PHARMA INCOME DATA
Net Sales Rs m472436425712851 
Other income Rs m31343721 
Total revenues Rs m785440427720872 
Gross profit Rs m-351-1311210393 
Depreciation Rs m4035334555 
Interest Rs m6921178 
Profit before tax Rs m-147-183-195852 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2211000 
Profit after tax Rs m-169-194-195852 
Gross profit margin %-74.5-30.02.914.511.0 
Effective tax rate %-14.9-5.8000 
Net profit margin %-35.8-44.4-4.48.26.1 
BAFNA PHARMA BALANCE SHEET DATA
Current assets Rs m487485361497514 
Current liabilities Rs m598708171243164 
Net working cap to sales %-23.5-51.244.735.641.1 
Current ratio x0.80.72.12.03.1 
Inventory Days Days346284000 
Debtors Days Days1,8792,078519490634 
Net fixed assets Rs m896710352368388 
Share capital Rs m23723724237237 
"Free" reserves Rs m143-46-66331392 
Net worth Rs m379191-42568629 
Long term debt Rs m232230302579 
Total assets Rs m1,3841,195713865902 
Interest coverage x-1.1-7.6-18.68.97.5 
Debt to equity ratio x0.61.2-0.700.1 
Sales to assets ratio x0.30.40.60.80.9 
Return on assets %-7.2-14.4-2.57.66.6 
Return on equity %-44.6-101.644.410.38.2 
Return on capital %-12.7-38.4146.111.18.4 
Exports to sales %00000 
Imports to sales %8.75.05.55.93.7 
Exports (fob) Rs m00000 
Imports (cif) Rs m4122244232 
Fx inflow Rs m207260250347548 
Fx outflow Rs m4122244232 
Net fx Rs m166239226305516 
BAFNA PHARMA CASH FLOW
From Operations Rs m -70 -18 -343 -136 80 
From Investments Rs m 380 154 328 -53 -54 
From Financial Activity Rs m -306 -138 73 123 -42 
Net Cashflow Rs m 3 -2 58 -67 -16 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 90.1%
Institution 0.0%
Non-Institution 9.9%
Total 100.0%
Free Float 9.9%
Pledged promoter holdings 0.0%
Shareholding as on Jun 2022
 

Company Information

Regd Off Bafna Towers, New No 68 Old No.299, Thambu Chetty Street, Chennai - 600001
E-mail info@bafnapharma.com Web www.bafnapharma.com
Tel 044- 25267517/25270992/42677555 Fax 044- 25231264
Sector PHARMACEUTICALS Group Private sector
Tr Agent Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
CHM: Bafna Mahaveer Chand COMP SEC: Jitendra Kumar Pal YEAR OF INC: 1995 BSE CODE: 532989 FV (Rs): 10 DIV YIELD (%): -

Read: BAFNA PHARMA 2021-22 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   LUPIN    PIRAMAL ENTERPRISES    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    

Compare BAFNA PHARMA With:   LUPIN    PIRAMAL ENTERPRISES    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    CIPLA    




Today's Market

Sensex Tumbles 500 Points, Nifty Below 17,000; Hindalco, Kotak Mahindra Bank & Maruti Suzuki Top Losers(10:30 am)

Asian share markets opened lower today, extending falls on Wall Street, where fears grew that monetary tightening could lead to a global recession.